{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:47:41Z","timestamp":1793155661629,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2016YFC1300600"],"award-info":[{"award-number":["2016YFC1300600"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["Z151100003915126"],"award-info":[{"award-number":["Z151100003915126"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neutral lipid storage disease with myopathy (NLSDM) is a rare clinical heterogeneous disorder caused by mutations in the patatin-like phospholipase domain-containing 2 (PNPLA2) gene. NLSDM usually presents skeletal myopathy, cardiomyopathy and the multiple organs dysfunction. Around 50 cases of NLSDM have been described worldwide, whereas the comprehensive understanding of this disease are still limited. We therefore recruit NLSDM patients from 10 centers across China, summarize the clinical, muscle imaging, pathological and genetic features, and analyze the genotype-phenotype relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 45 NLSDM patients (18 men and 27 women) were recruited from 40 unrelated families. Thirteen patients were born from consanguineous parents. The phenotypes were classified as asymptomatic hyperCKemia (2\/45), pure skeletal myopathy (18\/45), pure cardiomyopathy (4\/45), and the combination of skeletal myopathy and cardiomyopathy (21\/45). Right upper limb weakness was the early and prominent feature in 61.5% of patients. On muscle MRI, the long head of the biceps femoris, semimembranosus and adductor magnus on thighs, the soleus and medial head of the gastrocnemius on lower legs showed the most severe fatty infiltration. Thirty-three families were carrying homozygous mutations, while seven families were carrying compound heterozygous mutations. A total of 23 mutations were identified including 11 (47.8%) point mutations, eight (34.8%) deletions and four (17.4%) insertions. c.757\u2009+\u20091G\u2009&gt;\u2009T, c.245G\u2009&gt;\u2009A and c.187\u2009+\u20091G\u2009&gt;\u2009A were the three most frequent mutations. Among four groups of phenotypes, significant differences were shown in disease onset (&lt;\u200920\u2009years versus \u226520\u2009years old,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.003) and muscle pathology (with rimmed vacuoles versus without rimmed vacuoles,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.001). PNPLA2 mutational type or functional defects did not show great impact on phenotypes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We outline the clinical and genetic spectrum in a large cohort of NLSDM patients. Selective muscle fatty infiltration on posterior compartment of legs are characteristic of NLSDM. Chinese patients present with distinctive and relative hotspot PNPLA2 mutations. The disease onset age and pathological appearance of rimmed vacuoles are proved to be related with the clinical manifestations. The phenotypes are not strongly influenced by genetic defects, suggesting the multiple environmental risk factors in the development of NLSDM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-019-1209-z","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T07:05:19Z","timestamp":1572073519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Neutral lipid storage disease with myopathy in China: a large multicentric cohort study"],"prefix":"10.1186","volume":"14","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daojun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3282-9123","authenticated-orcid":false,"given":"Yun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,26]]},"reference":[{"key":"1209_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ng1951","volume":"39","author":"J Fischer","year":"2007","unstructured":"Fischer J, Lef\u00e8vre C, Morava E, Mussini JM, Lafor\u00eat P, Negre-Salvayre A, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet. 2007;39:28\u201330.","journal-title":"Nat Genet"},{"key":"1209_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1086\/324121","volume":"69","author":"C Lef\u00e8vre","year":"2001","unstructured":"Lef\u00e8vre C, Jobard F, Caux F, Bouadjar B, Karaduman A, Heilig R, et al. Mutations in CGI-58, the gene encoding a new protein of the esterase\/lipase\/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet. 2001;69:1002\u201312.","journal-title":"Am J Hum Genet"},{"key":"1209_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","volume":"24","author":"K Kaneko","year":"2014","unstructured":"Kaneko K, Kuroda H, Izumi R, Tateyama M, Kato M, Sugimura K, et al. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review. Neuromuscul Disord. 2014;24:634\u201341.","journal-title":"Neuromuscul Disord"},{"key":"1209_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13023-017-0646-9","volume":"12","author":"EM Pennisi","year":"2017","unstructured":"Pennisi EM, Arca M, Bertini E, Bruno C, Cassandrini D, D'amico A, et al. Neutral lipid storage diseases: clinical\/genetic features and natural history in a large cohort of Italian patients. Orphanet J Rare Dis. 2017;12:90.","journal-title":"Orphanet J Rare Dis"},{"key":"1209_CR5","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00415-011-6055-4","volume":"258","author":"P Reilich","year":"2011","unstructured":"Reilich P, Horvath R, Krause S, Schramm N, Turnbull DM, Trenell M, et al. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene. J Neurol. 2011;258:1987\u201397.","journal-title":"J Neurol"},{"key":"1209_CR6","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.nmd.2013.08.008","volume":"23","author":"L Perrin","year":"2013","unstructured":"Perrin L, F\u00e9asson L, Furby A, Lafor\u00eat P, Petit FM, Gautheron V, et al. PNPLA2 mutation: a paediatric case with early onset but indolent course. Neuromuscul Disord. 2013;23:986\u201391.","journal-title":"Neuromuscul Disord"},{"key":"1209_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ejhg.2012.256","volume":"21","author":"MC Janssen","year":"2013","unstructured":"Janssen MC, van Engelen B, Kapusta L, Lammens M, van Dijk M, Fischer J, et al. Symptomatic lipid storage in carriers for the PNPLA2 gene. Eur J Hum Genet. 2013;21:807\u201315.","journal-title":"Eur J Hum Genet"},{"key":"1209_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbrc.2012.10.127","volume":"430","author":"C Fiorillo","year":"2013","unstructured":"Fiorillo C, Brisca G, Cassandrini D, Scapolan S, Astrea G, Valle M, et al. Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene. Biochem Biophys Res Commun. 2013;430:241\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"1209_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.nmd.2008.06.382","volume":"18","author":"A Ohkuma","year":"2008","unstructured":"Ohkuma A, Nonaka I, Malicdan MC, Noguchi S, Ohji S, Nomura K, et al. Distal lipid storage myopathy due to PNPLA2 mutation. Neuromuscul Disord. 2008;18:671\u20134.","journal-title":"Neuromuscul Disord"},{"key":"1209_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5414\/NPP29351","volume":"29","author":"J Chen","year":"2010","unstructured":"Chen J, Hong D, Wang Z, Yuan Y. A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles. Clin Neuropathol. 2010;29:351\u20136.","journal-title":"Clin Neuropathol"},{"key":"1209_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijcard.2016.01.137","volume":"207","author":"MB Pasanisi","year":"2016","unstructured":"Pasanisi MB, Missaglia S, Cassandrini D, Salerno F, Farina S, Andreini D, et al. Severe cardiomyopathy in a young patient with complete deficiency of adipose triglyceride lipase due to a novel mutation in PNPLA2 gene. Int J Cardiol. 2016;207:165\u20137.","journal-title":"Int J Cardiol"},{"key":"1209_CR12","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/mus.24507","volume":"51","author":"C Xu","year":"2015","unstructured":"Xu C, Zhao Y, Liu J, Zhang W, Wang Z, Yuan Y. Muscle MRI in neutral lipid storage disease with myopathy carrying mutation c.187+1G>a. Muscle Nerve. 2015;51:922\u20137.","journal-title":"Muscle Nerve"},{"key":"1209_CR13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/mus.20869","volume":"36","author":"M Akiyama","year":"2007","unstructured":"Akiyama M, Sakai K, Ogawa M, McMillan JR, Sawamura D, Shimizu H. Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. Muscle Nerve. 2007;36:856\u20139.","journal-title":"Muscle Nerve"},{"key":"1209_CR14","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMc0805305","volume":"359","author":"K Hirano","year":"2008","unstructured":"Hirano K, Ikeda Y, Zaima N, Sakata Y, Matsumiya G. Triglyceride deposit cardiomyovasculopathy. N Engl J Med. 2008;359:2396\u20138.","journal-title":"N Engl J Med"},{"key":"1209_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/mus.24983","volume":"53","author":"R Massa","year":"2016","unstructured":"Massa R, Pozzessere S, Rastelli E, Serra L, Terracciano C, Gibellini M, et al. Neutral lipid-storage disease with myopathy and extended phenotype with novel PNPLA2 mutation. Muscle Nerve. 2016;53:644\u20138.","journal-title":"Muscle Nerve"},{"key":"1209_CR16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1007\/s00415-017-8498-8","volume":"264","author":"M Garibaldi","year":"2017","unstructured":"Garibaldi M, Tasca G, Diaz-Manera J, Ottaviani P, Laschena F, Pantoli D, et al. Muscle MRI in neutral lipid storage disease (NLSD). J Neurol. 2017;264:1334\u201342.","journal-title":"J Neurol"},{"key":"1209_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ymgme.2012.12.004","volume":"108","author":"P Lafor\u00eat","year":"2013","unstructured":"Lafor\u00eat P, Stojkovic T, Bassez G, Carlier PG, Cl\u00e9ment K, Wahbi K, et al. Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study. Mol Genet Metab. 2013;108:125\u201331.","journal-title":"Mol Genet Metab"},{"key":"1209_CR18","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1210\/jc.2007-2247","volume":"93","author":"K Kobayashi","year":"2008","unstructured":"Kobayashi K, Inoguchi T, Maeda Y, Nakashima N, Kuwano A, Eto E, et al. The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J Clin Endocrinol Metab. 2008;93:2877\u201384.","journal-title":"J Clin Endocrinol Metab"},{"key":"1209_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ymgme.2015.05.001","volume":"115","author":"S Missaglia","year":"2015","unstructured":"Missaglia S, Tasca E, Angelini C, Moro L, Tavian D. Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings. Mol Genet Metab. 2015;115:110\u20137.","journal-title":"Mol Genet Metab"},{"key":"1209_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nmd.2017.01.011","volume":"27","author":"S Missaglia","year":"2017","unstructured":"Missaglia S, Maggi L, Mora M, Gibertini S, Blasevich F, Agostoni P, et al. Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement. Neuromuscul Disord. 2017;27:481\u20136.","journal-title":"Neuromuscul Disord"},{"key":"1209_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/jhg.2012.84","volume":"57","author":"P Lin","year":"2012","unstructured":"Lin P, Li W, Wen B, Zhao Y, Fenster DS, Wang Y, et al. Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy. J Hum Genet. 2012;57:679\u201381.","journal-title":"J Hum Genet"},{"key":"1209_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.clineuro.2018.03.001","volume":"168","author":"J Tan","year":"2018","unstructured":"Tan J, Yang H, Fan J, Fan Y, Xiao F. Patients with neutral lipid storage disease with myopathy (NLSDM) in southwestern China. Clin Neurol Neurosurg. 2018;168:102\u20137.","journal-title":"Clin Neurol Neurosurg"},{"key":"1209_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/ejpn.2002.0617","volume":"6","author":"E Mercuri","year":"2002","unstructured":"Mercuri E, Pichiecchio A, Counsell S, Allsop J, Cini C, Jungbluth H, et al. A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol. 2002;6:305\u20137.","journal-title":"Eur J Paediatr Neurol"},{"key":"1209_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/keu422","volume":"54","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Liu L, Wang L, Xiao J, Wang Z, Lv H, et al. Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle. Rheumatology (Oxford). 2015;54:1017\u201324.","journal-title":"Rheumatology (Oxford)"},{"key":"1209_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nmd.2010.04.004","volume":"20","author":"HO Akman","year":"2010","unstructured":"Akman HO, Davidzon G, Tanji K, Macdermott EJ, Larsen L, Davidson MM, et al. Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene. Neuromuscul Disord. 2010;20:397\u2013402.","journal-title":"Neuromuscul Disord"},{"key":"1209_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcard.2015.05.004","volume":"192","author":"M Higashi","year":"2015","unstructured":"Higashi M, Hirano K, Kobayashi K, Ikeda Y, Issiki A, Otsuka T, et al. Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase. Int J Cardiol. 2015;192:30\u20132.","journal-title":"Int J Cardiol"},{"key":"1209_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archneurol.2011.631","volume":"69","author":"P Lafor\u00eat","year":"2012","unstructured":"Lafor\u00eat P, \u00d8rngreen M, Preisler N, Andersen G, Vissing J. Blocked muscle fat oxidation during exercise in neutral lipid storage disease. Arch Neurol. 2012;69:530\u20133.","journal-title":"Arch Neurol"},{"issue":"07","key":"1209_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5414\/NP301159","volume":"38","author":"Daojun Hong","year":"2019","unstructured":"Hong D, Zheng J, Xin L, Xiang Y, Luan X, Cao L, et al. Clinical findings and autophagic pathology in neutral lipid storage disease with myopathy. Clin Neuropathol. 2019. \n                    https:\/\/doi.org\/10.5414\/NP301159\n                    \n                  .","journal-title":"Clinical Neuropathology"},{"key":"1209_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nmd.2011.05.002","volume":"21","author":"M Oliv\u00e9","year":"2011","unstructured":"Oliv\u00e9 M, Odgerel Z, Mart\u00ednez A, Poza JJ, Bragado FG, Zabalza RJ, et al. Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord. 2011;21:533\u201342.","journal-title":"Neuromuscul Disord"},{"key":"1209_CR30","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ana.24640","volume":"79","author":"G Tasca","year":"2016","unstructured":"Tasca G, Monforte M, Ottaviani P, Pelliccioni M, Frusciante R, Laschena F, et al. Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials. Ann Neurol. 2016;79:854\u201364.","journal-title":"Ann Neurol"},{"key":"1209_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fneur.2018.00456","volume":"9","author":"E Bugiardini","year":"2018","unstructured":"Bugiardini E, Morrow JM, Shah S, Wood CL, Lynch DS, Pitmann AM, et al. The diagnostic value of MRI pattern recognition in distal myopathies. Front Neurol. 2018;9:456.","journal-title":"Front Neurol"},{"key":"1209_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrd2032","volume":"5","author":"V Regitz-Zagrosek","year":"2006","unstructured":"Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov. 2006;5:425\u201338.","journal-title":"Nat Rev Drug Discov"},{"key":"1209_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nmd.2017.11.003","volume":"28","author":"W Zhu","year":"2018","unstructured":"Zhu W, Eto M, Mitsuhashi S, Takata K, Beck G, Sumi-Akamaru H, et al. GNE myopathy caused by a synonymous mutation leading to aberrant mRNA splicing. Neuromuscul Disord. 2018;28:154\u20137.","journal-title":"Neuromuscul Disord"},{"key":"1209_CR34","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1093\/hmg\/dds388","volume":"21","author":"D Tavian","year":"2012","unstructured":"Tavian D, Missaglia S, Redaelli C, Pennisi EM, Invernici G, Wessalowski R, et al. Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function. Hum Mol Genet. 2012;21:5318\u201328.","journal-title":"Hum Mol Genet"},{"key":"1209_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.nmd.2018.04.010","volume":"28","author":"CS Latimer","year":"2018","unstructured":"Latimer CS, Schleit J, Reynolds A, Marshall DA, Podemski B, Wang LH, et al. Neutral lipid storage disease with myopathy: further phenotypic characterization of a rare PNPLA2 variant. Neuromuscul Disord. 2018;28:606\u20139.","journal-title":"Neuromuscul Disord"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1209-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T19:17:31Z","timestamp":1603567051000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1209-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,26]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1209"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1209-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,26]]},"assertion":[{"value":"14 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the ethical standards of the responsible committees on human experimentation and approved by the Institutional Review Board (no. 2011[419]). Informed consent for all examinations was obtained from the patients or their guardians. The protocol in the study strictly followed the rules of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}